Scopolamine for the treatment of depression and anxiety

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 31/46 (2006.01) A61K 9/12 (2006.01) A61P 25/22 (2006.01) A61P 25/24 (2006.01)

Patent

CA 2610025

Provided herein are methods and compositions for the treatment of depression and anxiety. The compositions comprise scopolamine, or an analog thereof, and can optionally include one or more psychoactive agents. Further provided is an inhaler comprising scopolamine, or an analog thereof, in a pharmaceutically acceptable carrier.

La présente invention se rapporte à des méthodes et à des compositions destinées à traiter la dépression et l'anxiété. Les compositions selon l'invention contiennent de la scopolamine ou un analogue de cette dernière, et peuvent éventuellement contenir aussi un ou plusieurs agents psychoactifs. L'invention a également trait à un inhalateur contenant de la scopolamine ou un analogue de cette dernière dans un excipient pharmaceutiquement acceptable.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Scopolamine for the treatment of depression and anxiety does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Scopolamine for the treatment of depression and anxiety, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Scopolamine for the treatment of depression and anxiety will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1981925

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.